These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
325 related items for PubMed ID: 4402951
1. Graft versus leukemia for "cell cure" of long-passage AKR leukemia after chemoradiotherapy. Saltzstein EC, Glasspiegel JS, Rimm AA, Giller RH, Bortin MM. Cancer Res; 1972 Aug; 32(8):1658-62. PubMed ID: 4402951 [No Abstract] [Full Text] [Related]
4. Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide. Truitt RL, Rose WC, Rimm AA, Bortin MM. Exp Hematol; 1978 May; 6(5):488-98. PubMed ID: 26584 [Abstract] [Full Text] [Related]
5. Further development of a successful protocol of graft versus leukemia without fatal graft-versus-host disease in AKR mice. Chester SJ, Esparza AR, Flinton LJ, Simon JD, Kelley RJ, Albala MM. Cancer Res; 1977 Oct; 37(10):3494-6. PubMed ID: 20223 [Abstract] [Full Text] [Related]
8. Graft-versus-leukemia. V. Absence of antileukemic effect using allogeneic h-2-identical immunocompetent cells. Bortin MM, Rimm AA, Rose WC, Saltzstein EC. Transplantation; 1974 Sep; 18(3):280-3. PubMed ID: 4154022 [No Abstract] [Full Text] [Related]
9. Graft-versus-leukemia for AKR spontaneous leukemia-lymphoma. Truitt RL, Rimm AA, Saltzstein EC, Rose WC, Bortin MM. Transplant Proc; 1976 Dec; 8(4):569-74. PubMed ID: 11589 [Abstract] [Full Text] [Related]
10. Transient graft-versus-host reaction in the treatment of leukemia in mice. Boranić M. J Natl Cancer Inst; 1968 Aug; 41(2):421-37. PubMed ID: 4876445 [No Abstract] [Full Text] [Related]
11. The effect of cyclophosphamide on the ability of graft-versus-host reaction to suppress leukaemia in mice. Boranić M, Tonković I. Rev Eur Etud Clin Biol; 1972 Mar; 17(3):314-20. PubMed ID: 4403351 [No Abstract] [Full Text] [Related]
12. Marrow transplantation for the treatment of acute leukemia using HL-A-identical siblings. Buckner CD, Clift RA, Fefer A, Lerner KG, Neiman PE, Storb R, Thomas ED. Transplant Proc; 1974 Dec; 6(4):365-6. PubMed ID: 4612892 [No Abstract] [Full Text] [Related]
13. Bone-marrow transplantation in France, 1958-1973. Mathé G, Schwarzenberg L. Transplant Proc; 1974 Dec; 6(4):335-43. PubMed ID: 4155150 [No Abstract] [Full Text] [Related]
15. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells. Bortin MM, Rimm AA, Saltzstein EC, Rodey GE. Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030 [No Abstract] [Full Text] [Related]
16. Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Johnson BD, Drobyski WR, Truitt RL. Bone Marrow Transplant; 1993 Apr; 11(4):329-36. PubMed ID: 8485480 [Abstract] [Full Text] [Related]
17. Marrow transplants in aplastic anemia and leukemia. Fefer A, Thomas ED, Buckner CD, Storb R, Neiman P, Glucksberg H, Clift RA, Lerner KG. Semin Hematol; 1974 Jul; 11(3):353-67. PubMed ID: 4151983 [No Abstract] [Full Text] [Related]
20. Treatment of an established graft-versus-host reaction in AKR mice by adoptive immunotherapy. Chester SJ, Esparza AR, Albala MM. Cancer Res; 1975 Mar; 35(3):634-6. PubMed ID: 234788 [Abstract] [Full Text] [Related] Page: [Next] [New Search]